Cartesian Therapeutics CVR
13F holders, Q1 2024 (March 31)3holders
$0.09avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Cartesian Therapeutics CVR in their 13F filings. The largest holders were Erste Asset Management GmbH ($253K), Ironwood Investment Management LLC ($0) and GAMMA Investing LLC ($0).
- Company
- Cartesian Therapeutics CVR
- CUSIP
- 816212112
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 3 holders
| Erste Asset Management GmbH | 0.00% | No change | 2,527,000 | $253K |
| Ironwood Investment Management LLC | 0.00% | Add +0.7% | 173,208 | $0 |
| GAMMA Investing LLC | 0.00% | No change | 237 | $0 |
"% of holder's portfolio" is Cartesian Therapeutics CVR's weight in each manager's 13F, not the share of Cartesian Therapeutics CVR the manager owns.